| The effectiveness of levocetirizine and desloratadine in up to 4 times conventional doses in difficult-to-treat urticaria M Staevska, TA Popov, T Kralimarkova, C Lazarova, S Kraeva, D Popova, ... Journal of Allergy and Clinical Immunology 125 (3), 676-682, 2010 | 435 | 2010 |
| International consensus on the diagnosis and management of pediatric patients with hereditary angioedema with C1 inhibitor deficiency H Farkas, I Martinez‐Saguer, K Bork, T Bowen, T Craig, M Frank, ... Allergy 72 (2), 300-313, 2017 | 213 | 2017 |
| Night‐time sedating H1‐antihistamine increases daytime somnolence but not treatment efficacy in chronic spontaneous urticaria: a randomized controlled trial M Staevska, M Gugutkova, C Lazarova, T Kralimarkova, V Dimitrov, ... British journal of dermatology 171 (1), 148-154, 2014 | 75 | 2014 |
| The global impact of the COVID‐19 pandemic on the management and course of chronic urticaria E Kocatürk, A Salman, I Cherrez‐Ojeda, PR Criado, J Peter, ... Allergy, 2020 | 69 | 2020 |
| International consensus on the use of genetics in the management of hereditary angioedema AE Germenis, M Margaglione, JB Pesquero, H Farkas, S Cichon, D Csuka, ... The Journal of Allergy and Clinical Immunology: In Practice 8 (3), 901-911, 2020 | 65 | 2020 |
| Rhinitis and sleep apnea MT Staevska, MA Mandajieva, VD Dimitrov Current allergy and asthma reports 4 (3), 193-199, 2004 | 52 | 2004 |
| Targeted next-generation sequencing for the molecular diagnosis of hereditary angioedema due to C1-inhibitor deficiency G Loules, M Zamanakou, F Parsopoulou, S Vatsiou, F Psarros, D Csuka, ... Gene 667, 76-82, 2018 | 43 | 2018 |
| Quality of life improvement after a three-year course of sublingual immunotherapy in patients with house dust mite and grass pollen induced allergic rhinitis: results from real … SM Novakova, MT Staevska, PI Novakova, MD Yoncheva, ... Health and Quality of Life Outcomes 15, 1-6, 2017 | 38 | 2017 |
| Real life clinical study design supporting the effectiveness of extra-fine inhaled beclomethasone/formoterol at the level of small airways of asthmatics TA Popov, D Petrova, TZ Kralimarkova, Y Ivanov, T Popova, M Peneva, ... Pulmonary pharmacology & therapeutics 26 (6), 624-629, 2013 | 37 | 2013 |
| A real–life observational pilot study to evaluate the effects of two-week treatment with montelukast in patients with chronic cough RK Mincheva, TZ Kralimarkova, M Rasheva, Z Dimitrov, D Nedeva, ... Cough 10, 1-6, 2014 | 29 | 2014 |
| Recombinant human C1 esterase inhibitor as short-term prophylaxis in patients with hereditary angioedema A Valerieva, M Staevska, M Jesenak, K Hrubiskova, M Sobotkova, ... The Journal of Allergy and Clinical Immunology: In Practice 8 (2), 799-802, 2020 | 28 | 2020 |
| A novel deep intronic SERPING1 variant as a cause of hereditary angioedema due to C1-inhibitor deficiency S Vatsiou, M Zamanakou, G Loules, F Psarros, F Parsopoulou, D Csuka, ... Allergology International 69 (3), 443-449, 2020 | 22 | 2020 |
| Effect of micronized cellulose powder on the efficacy of topical oxymetazoline in allergic rhinitis A Valerieva, TA Popov, M Staevska, T Kralimarkova, E Petkova, ... Allergy Asthma Proc 36 (6), e134-139, 2015 | 20 | 2015 |
| Differential diagnosis of persistent nonallergic rhinitis and rhinosinusitis syndromes MT Staevska, JN Baraniuk Nonallergic Rhinitis, 57-76, 2016 | 16 | 2016 |
| Persistent nonallergic rhinosinusitis M Staevska, JN Baraniuk Current Allergy and Asthma Reports 5 (3), 233-242, 2005 | 13 | 2005 |
| Hormonal effects on urticaria and angioedema conditions JA Bernstein, L Bouillet, T Caballero, M Staevska The Journal of Allergy and Clinical Immunology: In Practice 9 (6), 2209-2219, 2021 | 10 | 2021 |
| Therapeutic management of hereditary angioedema: past, present, and future A Valerieva, D Nedeva, V Yordanova, E Petkova, M Staevska Balkan Medical Journal 38 (2), 89, 2021 | 10 | 2021 |
| Characteristics of a patient population seeking medical advice for nasal symptoms in Bulgaria TA Popov, TZ Kralimarkova, MT Staevska, VD Dimitrov Annals of Allergy, Asthma & Immunology 108 (4), 232-236, 2012 | 7 | 2012 |
| Efficacy and safety of bradykinin B2 receptor inhibition with oral PHVS416 in treating hereditary angioedema attacks: results of RAPIDe-1 phase 2 trial M Maurer, J Anderson, E Aygören-Pürsün, L Bouillet, ML Baeza, ... Journal of Allergy and Clinical Immunology 151 (2), AB134, 2023 | 6 | 2023 |
| Recombinant human C1 esterase inhibitor for hereditary angioedema attacks: A European registry A Valerieva, MT Staevska, V Grivcheva-Panovska, M Jesenak, ... World Allergy Organization Journal 14 (4), 100535, 2021 | 6 | 2021 |
